Literature DB >> 33512764

EVL regulates VEGF receptor-2 internalization and signaling in developmental angiogenesis.

Joana Zink1,2, Maike Frye3, Timo Frömel1,2, Claudia Carlantoni3, David John2,4, Danny Schreier3, Andreas Weigert5, Hebatullah Laban6, Gabriela Salinas7, Heike Stingl1,2, Lea Günther1,2, Rüdiger Popp1,2, Jiong Hu1,2, Benoit Vanhollebeke8, Hannes Schmidt9, Amparo Acker-Palmer10, Thomas Renné3, Ingrid Fleming1,2, Peter M Benz1,2.   

Abstract

Endothelial tip cells are essential for VEGF-induced angiogenesis, but underlying mechanisms are elusive. The Ena/VASP protein family, consisting of EVL, VASP, and Mena, plays a pivotal role in axon guidance. Given that axonal growth cones and endothelial tip cells share many common features, from the morphological to the molecular level, we investigated the role of Ena/VASP proteins in angiogenesis. EVL and VASP, but not Mena, are expressed in endothelial cells of the postnatal mouse retina. Global deletion of EVL (but not VASP) compromises the radial sprouting of the vascular plexus in mice. Similarly, endothelial-specific EVL deletion compromises the radial sprouting of the vascular plexus and reduces the endothelial tip cell density and filopodia formation. Gene sets involved in blood vessel development and angiogenesis are down-regulated in EVL-deficient P5-retinal endothelial cells. Consistently, EVL deletion impairs VEGF-induced endothelial cell proliferation and sprouting, and reduces the internalization and phosphorylation of VEGF receptor 2 and its downstream signaling via the MAPK/ERK pathway. Together, we show that endothelial EVL regulates sprouting angiogenesis via VEGF receptor-2 internalization and signaling.
© 2021 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Keywords:  Ena/VASP proteins; VEGF receptor 2 internalization and signaling; endothelial cells; sprouting angiogenesis; tip cell filopodia formation

Mesh:

Substances:

Year:  2021        PMID: 33512764      PMCID: PMC7857432          DOI: 10.15252/embr.201948961

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  75 in total

Review 1.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

2.  A conditional knockout resource for the genome-wide study of mouse gene function.

Authors:  William C Skarnes; Barry Rosen; Anthony P West; Manousos Koutsourakis; Wendy Bushell; Vivek Iyer; Alejandro O Mujica; Mark Thomas; Jennifer Harrow; Tony Cox; David Jackson; Jessica Severin; Patrick Biggs; Jun Fu; Michael Nefedov; Pieter J de Jong; A Francis Stewart; Allan Bradley
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Ena/VASP Enabled is a highly processive actin polymerase tailored to self-assemble parallel-bundled F-actin networks with Fascin.

Authors:  Jonathan D Winkelman; Colleen G Bilancia; Mark Peifer; David R Kovar
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

4.  Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity.

Authors:  Biao Wang; Yang Xiao; Bei Bei Ding; Na Zhang; Xiao bin Yuan; Lü Gui; Kai Xian Qian; Shumin Duan; Zhengjun Chen; Yi Rao; Jian Guo Geng
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

5.  Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function.

Authors:  Guido Serini; Donatella Valdembri; Sara Zanivan; Giulia Morterra; Constanze Burkhardt; Francesca Caccavari; Luca Zammataro; Luca Primo; Luca Tamagnone; Malcolm Logan; Marc Tessier-Lavigne; Masahiko Taniguchi; Andreas W Püschel; Federico Bussolino
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

6.  Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains.

Authors:  S M Ahern-Djamali; A R Comer; C Bachmann; A S Kastenmeier; S K Reddy; M C Beckerle; U Walter; F M Hoffmann
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

7.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

8.  Characterization of EVL-I as a protein kinase D substrate.

Authors:  Katrien Janssens; Line De Kimpe; Michele Balsamo; Sandy Vandoninck; Jackie R Vandenheede; Frank Gertler; Johan Van Lint
Journal:  Cell Signal       Date:  2008-10-29       Impact factor: 4.315

9.  Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis.

Authors:  M G Coppolino; M Krause; P Hagendorff; D A Monner; W Trimble; S Grinstein; J Wehland; A S Sechi
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Ena/VASP regulates mDia2-initiated filopodial length, dynamics, and function.

Authors:  Melanie Barzik; Leslie M McClain; Stephanie L Gupton; Frank B Gertler
Journal:  Mol Biol Cell       Date:  2014-07-02       Impact factor: 4.138

View more
  2 in total

1.  Gatekeeping role of Nf2/Merlin in vascular tip EC induction through suppression of VEGFR2 internalization.

Authors:  Jung Hyun Bae; Myung Jin Yang; Seung-Hwan Jeong; JungMo Kim; Seon Pyo Hong; Jin Woo Kim; Yoo Hyung Kim; Gou Young Koh
Journal:  Sci Adv       Date:  2022-06-10       Impact factor: 14.957

2.  EVL regulates VEGF receptor-2 internalization and signaling in developmental angiogenesis.

Authors:  Joana Zink; Maike Frye; Timo Frömel; Claudia Carlantoni; David John; Danny Schreier; Andreas Weigert; Hebatullah Laban; Gabriela Salinas; Heike Stingl; Lea Günther; Rüdiger Popp; Jiong Hu; Benoit Vanhollebeke; Hannes Schmidt; Amparo Acker-Palmer; Thomas Renné; Ingrid Fleming; Peter M Benz
Journal:  EMBO Rep       Date:  2021-01-29       Impact factor: 8.807

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.